Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.

BACKGROUND AND OBJECTIVES Aberrant promoter methylation targets CpG islands causing gene silencing. We explored aberrant promoter methylation of genes potentially involved in B-cell malignancies and encoding proteins implicated in DNA repair (O6-methylguanine-DNA methyltransferase, MGMT), detoxification of environmental xenobiotics (glutathione S-transferase P1, GSTP1), apoptosis regulation (death associated protein kinase, DAP-k and caspase 8, CASP8) and cell cycle control (p73). DESIGN AND METHODS Three hundred and seventeen B-cell malignancies were investigated by methylation-specific polymerase chain reaction (MSP) of MGMT, GSTP1, DAP-k, CASP8 and p73 genes. In selected cases, MSP results were matched to protein expression studies by immunohistochemistry or Western blotting. RESULTS DAP-k promoter methylation occurred at highest frequency in follicular lymphoma (85.0%) and MALT-lymphoma (72.2%). MGMT methylation targeted both precursor B-cell neoplasia (23.8%) and mature B-cell tumors (27.6%). GSTP1 methylation was commonest in hairy cell leukemia (75.0%), follicular lymphoma (55.5%), Burkitt s lymphoma (52.0%), and MALT lymphoma (50.0%). Methylation of p73 and CASP8 was rare or absent. DAP-k and MGMT methylation caused absent protein expression. INTERPRETATION AND CONCLUSIONS Methylation of MGMT, DAP-k and GSTP1 represents a major pathogenetic event in several B-cell malignancies. In follicular lymphoma and MALT lymphoma, frequent inactivation of the apoptosis extrinsic pathway through DAP-k methylation may reinforce the survival advantage already conferred by deregulation of the intrinsic apoptotic pathway. Inactivation of GSTP1 in gastric MALT lymphoma represents an additional mechanism favoring accumulation of reactive oxygen species and lymphomagenesis. Finally, the frequency of GSTP1 aberrant methylation in diffuse large B-cell lymphoma prompts studies aimed at verifying the prognostic impact of this epigenetic lesion in these lymphomas.

[1]  D. Rossi,et al.  Frequent aberrant promoter hypermethylation of O6‐methylguanine‐DNA methyltransferase and death‐associated protein kinase genes in immunodeficiency‐related lymphomas , 2003, British journal of haematology.

[2]  K. Maclennan,et al.  Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. , 2003, Blood.

[3]  S. Koscielny,et al.  Prognostic value of GST-π expression in diffuse large B-cell lymphomas , 2003, Leukemia.

[4]  A. Sánchez-Aguilera,et al.  Cell cycle deregulation in B-cell lymphomas. , 2003, Blood.

[5]  J. Benítez,et al.  Frequent inactivation of the p73 gene by abnormal methylation or LOH in non‐Hodgkin's lymphomas , 2002, International journal of cancer.

[6]  I. Kerridge,et al.  Association between xenobiotic gene polymorphisms and non‐Hodgkin's lymphoma risk , 2002, British journal of haematology.

[7]  M. Ng,et al.  Death associated protein kinase: From regulation of apoptosis to tumor suppressive functions and B cell malignancies , 2002, Apoptosis.

[8]  John Calvin Reed,et al.  Dysregulation of apoptosis genes in hematopoietic malignancies , 2002, Oncogene.

[9]  D. Hossfeld.  E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[10]  S. Goodman,et al.  Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. , 2002, Journal of the National Cancer Institute.

[11]  L. Hutchins,et al.  Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. , 2001, Cancer research.

[12]  J. Herman,et al.  Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. , 2001, Cancer research.

[13]  P. Souček,et al.  Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. , 2001, Human molecular genetics.

[14]  Keith D Robertson,et al.  DNA methylation, methyltransferases, and cancer , 2001, Oncogene.

[15]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[16]  J. Issa,et al.  Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications , 2001, Annals of Internal Medicine.

[17]  F. Behm,et al.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.

[18]  A. Pegg.  Repair of O6-alkylguanine by alkyltransferases , 2000 .

[19]  F. Bosman,et al.  Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas. , 1999, Blood.

[20]  C. Bartram,et al.  Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. , 1999, Blood.

[21]  J. Herman,et al.  Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. , 1999, Cancer research.

[22]  A. Kimchi,et al.  Dap-Kinase Participates in TNF-α–And FAS-Induced Apoptosis and Its Function Requires the Death Domain , 1999, The Journal of cell biology.

[23]  M. Dolan,et al.  Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity. , 1999, Cancer research.

[24]  J. Herman,et al.  Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. , 1999, Blood.

[25]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.

[26]  J. Herman,et al.  Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. , 1998, Cancer research.

[27]  M. Volm,et al.  O6‐methylguanine‐DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts , 1998, International journal of cancer.

[28]  C. Wolf,et al.  Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Shimizu,et al.  Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. , 1997, Cancer research.

[30]  J. Allay,et al.  Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[33]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[34]  E. Scarano,et al.  DNA Methylation , 1973, Nature.

[35]  W. Au,et al.  Aberrant promoter methylation in gastric lymphoma. , 2003, Haematologica.

[36]  D. Rossi,et al.  Messengers of cell death: apoptotic signaling in health and disease. , 2003, Haematologica.

[37]  M. Schrappe,et al.  Polymorphisms within glutathione S-transferase genes in pediatric non-Hodgkin's lymphoma. , 2002, Haematologica.

[38]  J. Hayes,et al.  GLUTATHIONE S-TRANSFERASE POLYMORPHISM AND THEIR BIOLOGICAL CONSEQUENCE , 2000 .

[39]  Gustavo Droguett,et al.  DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation , 2000, Nature Cell Biology.

[40]  A. Pegg.  Repair of O(6)-alkylguanine by alkyltransferases. , 2000, Mutation research.

[41]  W. Kaelin,et al.  p73 is a simian [correction of human] p53-related protein that can induce apoptosis. , 1997, Nature.

[42]  T. Brent,et al.  Immunoaffinity purification of human O6-alkylguanine-DNA alkyltransferase using newly developed monoclonal antibodies. , 1990, Cancer research.